首页> 外国专利> Cardiac treatment system for sensing and responding to heart failure

Cardiac treatment system for sensing and responding to heart failure

机译:用于感测和应对心力衰竭的心脏治疗系统

摘要

A pacing system for determining a heart failure condition such as left ventricular dysfunction in a patient are provided, based upon obtaining information from cardiac signals, which information is processed and examined for a indication of the onset or progression of LVD. Since LVD is generally characterized by conduction disorders and other body responses calling for different heart rates during exercise, an examination of sensed cardiac signals is utilized to obtain data reflective of an LVD condition. In one embodiment, a QT rate responsive pacemaker (50) is utilized, wherein variations in QT interval corresponding to heart rate are detected and stored (40, 42), and then periodically analyzed (44; 74; 86) to detect changes of sufficient magnitude to indicate onset of LVD. In another embodiment, changes in lower natural rate at nighttime or rest are monitored ad analyzed for detection for a trend indicating LVD (82-86). Other cardiac signal parameters, such as T-wave amplitude changes during exercise, and QRS duration changes, can also be processed to obtain information from which LVD can be determined. When a LVD indication is made, the system responds automatically so as to take initial steps to treat the condition. Thus, in one embodiment, the control of pacing rate is altered so as to be better responsive to patient exercise (94). In another embodiment, 3- or 4-chamber pacing is initiated. In yet another embodiment, drug therapy is automatically administered.
机译:基于从心脏信号获得信息,提供了用于确定诸如患者的左心室功能障碍的心力衰竭状况的起搏系统,对该信息进行处理和检查以指示LVD的发作或进展。由于LVD通常以传导障碍和其他身体反应为特征,因此在运动过程中需要不同的心率,因此对检测到的心脏信号进行检查即可获得反映LVD状况的数据。在一实施例中,利用QT速率响应起搏器(50),其中检测并存储(40、42)与心率相对应的QT间隔的变化,然后对其进行定期分析(44; 74; 86)以检测足够的变化。表示LVD发作的幅度。在另一个实施例中,监测夜间或休息时较低自然率的变化,并对其进行分析以检测指示LVD的趋势(82-86)。其他心脏信号参数,例如运动期间的T波振幅变化和QRS持续时间变化,也可以进行处理以获得可确定LVD的信息。发出LVD指示后,系统会自动做出响应,从而采取初始步骤来治疗该疾病。因此,在一个实施例中,改变起搏速率的控制以便更好地响应患者运动(94)。在另一个实施例中,发起3室或4室起搏。在另一个实施方案中,药物疗法是自动施用的。

著录项

  • 公开/公告号EP0920885B1

    专利类型

  • 公开/公告日2004-04-28

    原文格式PDF

  • 申请/专利权人 VITATRON MEDICAL BV;

    申请/专利号EP19980122974

  • 发明设计人 BOUTE WILLEM;

    申请日1998-12-03

  • 分类号A61N1/365;A61N1/37;

  • 国家 EP

  • 入库时间 2022-08-21 22:57:55

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号